Carasent ASA
Carasent AB (publ) provides cloud based electronic health record (EHR) systems solutions and platform services for healthcare sector in Nordics and Germany. The company offers Webdoc, Webdoc X, Metodika, Ad Curis, Ad Opus, and Data-AL solutions. It also provides Medrave, Vårdrummet, Ad Voca, and HPI Plustoo services, as well as an ecosystem of platform services, including solutions for patient co… Read more
Carasent ASA (CARA) - Net Assets
Latest net assets as of December 2025: Skr808.00 Million SEK
Based on the latest financial reports, Carasent ASA (CARA) has net assets worth Skr808.00 Million SEK as of December 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Skr941.01 Million) and total liabilities (Skr133.00 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Skr808.00 Million |
| % of Total Assets | 85.87% |
| Annual Growth Rate | 12.52% |
| 5-Year Change | -31.02% |
| 10-Year Change | 1547.33% |
| Growth Volatility | 86.44 |
Carasent ASA - Net Assets Trend (2002–2025)
This chart illustrates how Carasent ASA's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Carasent ASA (2002–2025)
The table below shows the annual net assets of Carasent ASA from 2002 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | Skr808.00 Million | -9.50% |
| 2024-12-31 | Skr892.87 Million | -6.55% |
| 2023-12-31 | Skr955.41 Million | -22.11% |
| 2022-12-31 | Skr1.23 Billion | +4.72% |
| 2021-12-31 | Skr1.17 Billion | +192.11% |
| 2020-12-31 | Skr400.98 Million | +342.69% |
| 2019-12-31 | Skr90.58 Million | -0.94% |
| 2018-12-31 | Skr91.43 Million | +49.24% |
| 2017-12-31 | Skr61.27 Million | +24.91% |
| 2016-12-31 | Skr49.05 Million | -31.37% |
| 2015-12-31 | Skr71.47 Million | -12.74% |
| 2014-12-31 | Skr81.90 Million | -37.38% |
| 2013-12-31 | Skr130.79 Million | +13.88% |
| 2012-12-31 | Skr114.85 Million | +0.71% |
| 2011-12-31 | Skr114.03 Million | +6.98% |
| 2010-12-31 | Skr106.59 Million | -12.22% |
| 2009-12-31 | Skr121.43 Million | -16.19% |
| 2008-12-31 | Skr144.89 Million | +20.53% |
| 2007-12-31 | Skr120.21 Million | -34.80% |
| 2006-12-31 | Skr184.38 Million | +162.34% |
| 2005-12-31 | Skr70.28 Million | +36.17% |
| 2004-12-31 | Skr51.61 Million | +22.48% |
| 2003-12-31 | Skr42.14 Million | -21.30% |
| 2002-12-31 | Skr53.55 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Carasent ASA's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 5979300000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | Skr500.00K | 0.06% |
| Other Components | Skr867.29 Million | 107.34% |
| Total Equity | Skr808.00 Million | 100.00% |
Carasent ASA Competitors by Market Cap
The table below lists competitors of Carasent ASA ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Daedong Ind
KO:000490
|
$103.59 Million |
|
Anzheng Fashion
SHG:603839
|
$103.61 Million |
|
SPEEDY HIRE LS-05
F:5HN
|
$103.62 Million |
|
KMC (Kuei Meng) International Inc
TW:5306
|
$103.65 Million |
|
Vivotek Inc
TW:3454
|
$103.53 Million |
|
Thejo Engineering Limited
NSE:THEJO
|
$103.49 Million |
|
Daesung Ind
KO:128820
|
$103.47 Million |
|
Surteco Group SE
XETRA:SUR
|
$103.45 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Carasent ASA's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 892,869,000 to 808,002,000, a change of -84,867,000 (-9.5%).
- Net income of 34,670,000 contributed positively to equity growth.
- Share repurchases of 108,430,000 reduced equity.
- Other factors decreased equity by 11,107,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Skr34.67 Million | +4.29% |
| Share Repurchases | Skr108.43 Million | -13.42% |
| Other Changes | Skr-11.11 Million | -1.37% |
| Total Change | Skr- | -9.50% |
Book Value vs Market Value Analysis
This analysis compares Carasent ASA's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.98x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has increased from 0.81x to 1.98x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2002-12-31 | Skr28.56 | Skr23.10 | x |
| 2003-12-31 | Skr18.13 | Skr23.10 | x |
| 2004-12-31 | Skr20.65 | Skr23.10 | x |
| 2005-12-31 | Skr26.33 | Skr23.10 | x |
| 2006-12-31 | Skr55.07 | Skr23.10 | x |
| 2007-12-31 | Skr27.49 | Skr23.10 | x |
| 2008-12-31 | Skr24.34 | Skr23.10 | x |
| 2009-12-31 | Skr13.68 | Skr23.10 | x |
| 2010-12-31 | Skr5.24 | Skr23.10 | x |
| 2011-12-31 | Skr5.60 | Skr23.10 | x |
| 2012-12-31 | Skr5.62 | Skr23.10 | x |
| 2013-12-31 | Skr6.42 | Skr23.10 | x |
| 2014-12-31 | Skr4.01 | Skr23.10 | x |
| 2015-12-31 | Skr3.51 | Skr23.10 | x |
| 2016-12-31 | Skr2.41 | Skr23.10 | x |
| 2017-12-31 | Skr3.01 | Skr23.10 | x |
| 2018-12-31 | Skr2.25 | Skr23.10 | x |
| 2019-12-31 | Skr2.23 | Skr23.10 | x |
| 2020-12-31 | Skr8.93 | Skr23.10 | x |
| 2021-12-31 | Skr17.45 | Skr23.10 | x |
| 2022-12-31 | Skr15.35 | Skr23.10 | x |
| 2023-12-31 | Skr12.29 | Skr23.10 | x |
| 2024-12-31 | Skr12.35 | Skr23.10 | x |
| 2025-12-31 | Skr11.65 | Skr23.10 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Carasent ASA utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 4.29%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 10.08%
- • Asset Turnover: 0.37x
- • Equity Multiplier: 1.16x
- Recent ROE (4.29%) is above the historical average (-14.64%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2002 | -194.29% | -829.29% | 0.21x | 1.13x | Skr-109.39 Million |
| 2003 | -102.31% | -194.99% | 0.45x | 1.16x | Skr-47.33 Million |
| 2004 | -92.14% | -126.40% | 0.58x | 1.26x | Skr-52.72 Million |
| 2005 | -60.41% | -77.09% | 0.39x | 2.01x | Skr-49.48 Million |
| 2006 | -20.19% | -27.92% | 0.48x | 1.50x | Skr-55.66 Million |
| 2007 | -115.23% | -65.84% | 0.95x | 1.84x | Skr-150.54 Million |
| 2008 | -39.74% | -24.60% | 0.95x | 1.69x | Skr-72.06 Million |
| 2009 | -16.82% | -8.16% | 1.29x | 1.60x | Skr-32.57 Million |
| 2010 | -17.15% | -8.05% | 1.16x | 1.84x | Skr-28.94 Million |
| 2011 | 3.68% | 1.73% | 1.21x | 1.76x | Skr-7.21 Million |
| 2012 | 6.15% | 2.95% | 1.13x | 1.85x | Skr-4.42 Million |
| 2013 | 3.63% | 1.87% | 1.13x | 1.72x | Skr-8.33 Million |
| 2014 | -96.74% | -31.95% | 1.09x | 2.79x | Skr-87.42 Million |
| 2015 | 84.28% | 19.91% | 1.39x | 3.04x | Skr53.09 Million |
| 2016 | 289.08% | 73.18% | 3.85x | 1.02x | Skr136.89 Million |
| 2017 | 33.15% | 0.00% | 0.00x | 1.01x | Skr14.18 Million |
| 2018 | -7.69% | -29.35% | 0.20x | 1.30x | Skr-16.18 Million |
| 2019 | 3.55% | 6.70% | 0.35x | 1.51x | Skr-5.85 Million |
| 2020 | -9.51% | -54.03% | 0.14x | 1.26x | Skr-78.23 Million |
| 2021 | -0.01% | -0.11% | 0.11x | 1.11x | Skr-117.28 Million |
| 2022 | 2.54% | 15.96% | 0.14x | 1.12x | Skr-91.49 Million |
| 2023 | -4.86% | -19.04% | 0.22x | 1.14x | Skr-141.99 Million |
| 2024 | -4.73% | -15.35% | 0.26x | 1.20x | Skr-131.55 Million |
| 2025 | 4.29% | 10.08% | 0.37x | 1.16x | Skr-46.13 Million |
Industry Comparison
This section compares Carasent ASA's net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $18,035,972
- Average return on equity (ROE) among peers: -60.60%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Carasent ASA (CARA) | Skr808.00 Million | -194.29% | 0.16x | $103.55 Million |
| Aino Health AB (AINO) | $407.00K | -224.32% | 13.69x | $1.11 Million |
| Kontigo Care AB (KONT) | $17.72 Million | -37.94% | 0.52x | $2.57 Million |
| Medhelp Care AB (MEDHLP) | $28.45 Million | 7.32% | 1.05x | $17.33 Million |
| Physitrack PLC (PTRK) | $25.57 Million | 12.53% | 0.51x | $5.20 Million |